iPSC-derived iMSCNew genes and gene editing Therapy(Kiji Therapeutics)

N/A

Report date: 2024/11/21 15:50:12

Base Information

Drug NameiPSC-derived iMSCNew genes and gene editing Therapy(Kiji Therapeutics)
Drug Alias NameKJ-03(Kiji Therapeutics)KJ03(Kiji Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKiji Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKiji Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A